Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Screening for compounds with the ability to overcome Pgp-mediated MDR.

A. Expression of Pgp in parental and multidrug-resistance cell line pairs. Both pairs of cell lines were analyzed through western blotting for the expression of Pgp (MDR1). B. Flow chart for primary/secondary screening and identification of hits.

More »

Fig 1 Expand

Fig 2.

Secondary screening with 118 compounds in both pairs of parental and resistant cell lines.

Growth inhibition of A2780/A2780-Pac-Res (A.) and KB-3-1 and KB-V1 (B.) cell line pairs by 15 hits confirmed in the secondary screening at 1μM concentration. C. Growth inhibition of both the cell line pairs by paclitaxel.

More »

Fig 2 Expand

Table 1.

Resistant Index (RI) of selected inhibitors in parental and resistant cell line pairs.

More »

Table 1 Expand

Fig 3.

Calcein AM Efflux assays in Pgp-overexpressing multidrug-resistant cell lines.

Calcein retention in KB-3-1/KB-V1 and A2780/A2780-Pac-Res parental and resistant cell line pairs. Calcein retention in the presence of DMSO, verapamil and CHIR-124 was determined through FACS analysis (A) or immunofluorescence (B) as described in the materials and methods.

More »

Fig 3 Expand

Fig 4.

Effect of tyrphostin-9, brefeldin A and elesclomol on Pgp inhibition using calcein AM efflux assay.

Calcein retention in parental and resistant cells was determined through FACS analysis following treatment with the indicated concentrations of tyrphostin-9, brefeldin A (A) and elesclomol (B).

More »

Fig 4 Expand

Fig 5.

The docking of CHIR-124 and PIK-75 with Pgp.

(A) Binding of CHIR-124 in the NBD1 of Pgp (PDB code: 4Q9H) (B) 2D presentation of the interactions of CHIR-124 with the amino acid residues of NBD1 (C) Binding of PIK-75 in the NBD1 of Pgp (D) 2D presentation of the interactions of PIK-75 with the amino acid residues of NBD1. (E) Inhibition of ATPase activity of Pgp by CHIR-124 and PIK-75. ATPase activity was measured using Pgp-Glo assay (Promega) as described in materials and methods. Samples were treated with 100 μM Na3VO4, 200 μM Verapamil, 2.5 μM CHIR-124 and PIK-75 or left untreated. Fold change in verapamil-treated and compound treated Pgp activity was calculated according to the manufacturer’s instructions.

More »

Fig 5 Expand